Jason C O'COnnor

Jason C O'COnnor

Auto-generated profile, based on publicly available information

Jason C O'COnnor

Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
RRRonna Robbins
Ronna Robbins
TCTiffany M Cortes
Tiffany M Cortes
JOJason C O'COnnor
Jason C O'COnnor
RJRozmin Jiwani
Rozmin Jiwani
MSMonica Serra
Monica Serra
Background: Fatigue is a strong predictor of negative health outcomes in older adults. Kynurenine, a metabolite of tryptophan, is strongly associated with fatigue. Reductions in fatigue are observed with exercise; however, exercise training does not completely alleviate symptoms. Branched-chain amino acids (BCAAs) have been shown to have advantageous effects on exercise performance and compete with kynurenine for transport into the central nervous system. Thus, the combination of BCAA and exercise may exert synergized effects of mental and physical fatigue. Therefore, we hypothesize that BCAA added to exercise will shift kynurenine metabolism toward enhanced synthesis of kynurenic acid, thereby reducing fatigue. Objective: This randomized, double-blind, placebo-controlled trial aims to compare the effects of acute (approximately 45 min) and chronic (8 wk) exercise with and without BCAA supplementation on mental and physical fatigue and assess whether the hypothesized outcomes are modulated by changes in kynurenine metabolism in 30 older adults (n=15, 50% per group). Methods: Older adults (aged 60-80 y) who do not exercise >2 days per week and self-report fatigue (≥3 on a scale of 1-10) will be recruited. Participants will be randomized to either the exercise+BCAA group or exercise+placebo group. Participants will engage in high-volume, moderate-intensity, whole-body exercise training (aerobic and resistance exercise; either in-person or web-based sessions) 3 times per week for 8 weeks. In addition, participants will consume daily either 100 mg/kg body weight of BCAA (2:1:1 leucine:isoleucine:valine) or placebo (maltodextrin) throughout the 8-week intervention. BCAA and placebo powders will be identical in color and dissolved in 400 mL of water and 2.5 g of a calorie-free water flavor enhancer. Muscle biopsies will be collected before and after the intervention after a 12-hour fast to examine changes in the biomarkers of tryptophan metabolism and inflammation. Our primary outcomes include changes in mental and physical fatigue and metabolism after the 8-week exercise training between the 2 groups. Mental and physical fatigue will be measured before and after the intervention. Mental fatigue will be subjectively assessed through the completion of validated questionnaires. Physical fatigue will be measured by isometric handgrip, 1-repetition maximum, chair rise, 400-meter walk, and cardiopulmonary exercise tests. Results: The study was funded in March 2022, with an anticipated projected data collection period lasting from January 2023 through December 2023. Conclusions: The discovery that kynurenine concentrations are associated with fatigue and are responsive to BCAA supplementation during exercise training could have important implications for the development of future interventions, both lifestyle and pharmacologic, to treat fatigue in older adults. Trial Registration: ClinicalTrials.gov NCT05484661; https://www.clinicaltrials.gov/study/NCT05484661 International Registered Report Identifier (IRRID): DERR1-10.2196/52199

10 December 2025 in Neuroinformatics
Verified
Journal Article
Open access
EMEllen McMullen
Ellen McMullen
Miguel de la FlorMiguel de la Flor
Miguel de la Flor
Gemunu GunaratneGemunu Gunaratne
Gemunu Gunaratne
JOJason O’cOnnor
Jason O’cOnnor
GRGregg Roman
Gregg Roman
The open field test is widely used in behavioral neuroscience, providing insights into exploration, anxiety, and the learning processes associated with habituation to novelty. Analyses of exploratory behaviors in open field areas rely heavily on movement changes over time. These activity measures are susceptible to confounds from group differences in locomotor abilities and only provide an indirect measure of learning during exploration. Considerable effort has been placed on identifying additional measures of behavior that can better describe changes in exploration and habituation of novelty. Two measures for enhanced analysis of exploration are coverage and directional persistence (P ++ ). Coverage measures the number of visits to segments of the arena boundary and represents the number of opportunities to habituate to the novelty of this boundary. P ++ measures the probability of continued movement in the same direction, reflecting goal-directed exploration, which decreases as the animal habituates the novel arena. Our new Python package, opynfield , calculates coverage, P ++ , and activity measures from open field tracking data. We further introduce versions of coverage and the analysis of additional motion probabilities. The package includes new, in-depth statistical approaches and data visualizations. We demonstrate the applicability of opynfield using experiments with Drosophila melanogaster in which we (1) validate opynfield ’s statistical tests, (2) substantiate coverage as a measure of novelty habituation, and (3) characterize behavioral differences in exploration. We also illustrate the utility of opynfield for analyzing rodent exploration by applying it to data from an experiment with Mus musculus . By leveraging full-density tracking data, opynfield facilitates a more nuanced understanding of exploration, potentially leading to improved insights into animal behavior and changes in learning, locomotor activity, and anxiety.

25 August 2023 in JMIR Preprints
Verified
Preprint
Open access
RRRonna Robbins
Ronna Robbins
TCTiffany M Cortes
Tiffany M Cortes
JOJason C O'Connor
Jason C O'Connor
RJRozmin Jiwani
Rozmin Jiwani
MSMonica Serra
Monica Serra
BACKGROUND Fatigue is a strong predictor of negative health outcomes in older adults. Kynurenine, a metabolite of tryptophan, is strongly associated with fatigue. Reductions in fatigue are observed with exercise; however, exercise training does not completely alleviate symptoms. Branched-chain amino acids (BCAAs) have been shown to have advantageous effects on exercise performance and compete with kynurenine for transport into the central nervous system. Thus, the combination of BCAA and exercise may exert synergized effects of mental and physical fatigue. Therefore, we hypothesize that BCAA added to exercise will shift kynurenine metabolism toward enhanced synthesis of kynurenic acid, thereby reducing fatigue. OBJECTIVE This randomized, double-blind, placebo-controlled trial aims to compare the effects of acute (approximately 45 min) and chronic (8 wk) exercise with and without BCAA supplementation on mental and physical fatigue and assess whether the hypothesized outcomes are modulated by changes in kynurenine metabolism in 30 older adults (n=15, 50% per group). METHODS Older adults (aged 60-80 y) who do not exercise >2 days per week and self-report fatigue (≥3 on a scale of 1-10) will be recruited. Participants will be randomized to either the exercise+BCAA group or exercise+placebo group. Participants will engage in high-volume, moderate-intensity, whole-body exercise training (aerobic and resistance exercise; either in-person or web-based sessions) 3 times per week for 8 weeks. In addition, participants will consume daily either 100 mg/kg body weight of BCAA (2:1:1 leucine:isoleucine:valine) or placebo (maltodextrin) throughout the 8-week intervention. BCAA and placebo powders will be identical in color and dissolved in 400 mL of water and 2.5 g of a calorie-free water flavor enhancer. Muscle biopsies will be collected before and after the intervention after a 12-hour fast to examine changes in the biomarkers of tryptophan metabolism and inflammation. Our primary outcomes include changes in mental and physical fatigue and metabolism after the 8-week exercise training between the 2 groups. Mental and physical fatigue will be measured before and after the intervention. Mental fatigue will be subjectively assessed through the completion of validated questionnaires. Physical fatigue will be measured by isometric handgrip, 1-repetition maximum, chair rise, 400-meter walk, and cardiopulmonary exercise tests. RESULTS The study was funded in March 2022, with an anticipated projected data collection period lasting from January 2023 through December 2023. CONCLUSIONS The discovery that kynurenine concentrations are associated with fatigue and are responsive to BCAA supplementation during exercise training could have important implications for the development of future interventions, both lifestyle and pharmacologic, to treat fatigue in older adults. CLINICALTRIAL ClinicalTrials.gov NCT05484661; https://www.clinicaltrials.gov/study/NCT05484661 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/52199

28 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
Mustafa MithaiwalaMustafa Mithaiwala
Mustafa Mithaiwala
NPNikki Phillips
Nikki Phillips
DNDylan Nguyen
Dylan Nguyen
SGSi Gao
Si Gao
BABhim Adhikari
Bhim Adhikari
AAAshley Acheson
Ashley Acheson
Early adulthood is a critical developmental period for the emergence of alcohol and substance use disorders (A/SUD). Young adults with family histories of A/SUD (FH+) have a higher risk for developing A/SUD themselves compared to individuals without such family histories (FH−). FH+ individuals often exhibit behavioral and cognitive alterations similar to those observed in A/SUD populations; however, A/SUD-related structural brain alterations have not been consistently observed in FH+ neuroimaging studies, which may reflect underlying heterogeneity in FH+ individuals. We compared n=79 FH+ and 128 FH− young adults (ages 18-25) on five regions of interest brain volumes identified from prior A/SUD neuroimaging mega-analyses. Additionally, we compared study participants who scored low and high on a novel family history integrated phenotype (FHIP) score that combined family history with key phenotypic variables related to FH+ status. FH+ participants displayed trend-level reductions in corpus callosum volumes compared to FH− participants. However, participants with high FHIP scores had significantly decreased whole corpus callosum and increased amygdala volumes compared to participants with low FHIP scores. Post hoc testing of corpus callosum subregions found that participants with high FHIP scores had significantly reduced mid-anterior corpus callosum volume. There were no differences in hippocampus, thalamus, or putamen volumes between FH or FHIP score-based groupings. FHIP scores were more sensitive than family history status alone in identifying structural brain differences in non-abusing healthy young adults. Corpus callosum and amygdala structural alterations present before the onset of A/SUD could represent potential neural substrates that contribute to higher A/SUD vulnerability.